A Study of Irinotecan Liposome in Advanced Pancreatic Cancer

NCT04796948 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG: Irinotecan liposome；oxaliplatin；5-FU(Fluorouracil Injection)；LV(Calcium Folinate Injection)

Sponsor

Jiangsu HengRui Medicine Co., Ltd.